is preferably with CpG as-described in the pending UK patent application GB 9820956.2.According to another embodiment of this invention, an immunogenic composition described herein is delivered to a host via antigen presenting cells (APCs), such as dendritic cells, macrophages, B cells, monocytes and other cells that may beengineered to be efficient APCs.